The somatomedin hypothesis: 2001

Endocrine Reviews

Volumn 22, Issue 1, 2001, Pages 53-74

  Le Roith, D ^a   Bondy, C ^a   Yakar, S ^a   Liu, J L ^a   Butler, A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOCRINE EFFECT; BODY GROWTH; DISEASE MODEL; GENE DELETION; HORMONE ACTION; HUMAN; HYPOPHYSIS; HYPOTHESIS; KNOCKOUT GENE; LIVER; MOUSE; NONHUMAN; PARACRINE SIGNALING; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0035115801     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.22.1.0419     Document Type: Review

References (222)

1. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro
2. Molecular and cellular aspects of the insulin-like growth factor I receptor
3. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways
4. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors
5. Suppression of interleukin-1 β-converting enzyme-mediated cell death by insulin-like growth factor
6. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans
7. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: Evidence for a role for IGF binding proteins
8. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults
9. Insulin-like growth factors in pediatric health and disease
10. The effect of hypophysectomy and growth hormone on the incorporation of labeled sulfate into tibila epiphyseal and nasal cartilage of the rat
11. The effect of hypophysectomy and growth hormone on cartilage sulfate metabolism
12. Synchronous activation of DNA synthesis in hypophysectomized rat cartilage by growth hormone
13. Stimulation of DNA synthesis in isolated chondrocytes by sulfation factor
14. Somatomedin: Proposed designation for sulphation factor
15. Sequence analysis of somatomedin-C: Confirmation of identity with insulin-like growth factor I
16. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin
17. Plasma-insulin activity in hypopituitarism
18. Insulin-like growth factor: A model for tertiary structure accounting for immunoreactivity and receptor binding
19. Tertiary structures, receptor binding, and antigenicity of insulin-like growth factors
20. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary
21. Evidence that somatomedin is synthesized by multiple tissues in the fetus
22. Sequence of a cDNA encoding guinea pig IGF-I
23. Isolation of rat testis cDNAs encoding an insulin-like growth factor I precursor
24. Sequence of cDNA encoding human insulin-like growth factor I precursor
25. Structure and expression of a chicken insulin-like growth factor I precursor
26. Molecular cloning of rat insulin-like growth factor 1 complementary deoxyribonucleic acids: Differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues
27. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution
28. Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxy-terminal E-peptides: Evidence for differential processing and regulation in liver
29. Differential expression of alternative 5′ untranslated regions in mRNAs encoding rat insulin-like growth factor I
30. Growth hormone stimulates longitudinal bone growth directly
31. Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats
32. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin
33. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth
34. Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate
35. A dual effector theory of growth-hormone action
36. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion
37. Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters
38. Establishment of a clonal cell line that differentiates into adipose cells in vitro
39. Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes
40. Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes
41. Acquisition of increased hormone sensitivity during in vitro adipocyte development
42. Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells
43. Growth hormone and the adipose conversion of 3T3 cells
44. Properties of growth hormone receptors in relation to the adipose conversion of 3T3 cells
45. Activity of human growth hormone and related polypeptides on the adipose conversion of 3T3 cells
46. Growth hormone and bone
47. Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination
48. A clonal analysis of the differentiation of 3T3-L1 preadipose cells: Role of insulin
49. Growth hormone as a cytokine
50. Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate
51. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo
52. Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy
53. Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone
54. Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis
55. The mouse intraovarian insulin-like growth factor I system: Departures from the rat paradigm
56. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
57. IGF-I is required for normal embryonic growth in mice
58. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
59. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients
60. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis
61. Effects of the somatomedins and insulin on myoblast differentiation in vitro
62. Growth hormone and the insulin-like growth factor system in myogenesis
63. Structure and evolution of the growth hormone gene family
64. Sequences of pituitary and placental lactogenic and growth hormones: Evolution from a primordial peptide by gene reduplication
65. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chain
66. Haemopoietic receptors and helical cytokines
67. A new cytokine receptor superfamily
68. Growth hormone secretory profiles in conscious female rats
69. Age- and sex-related differences in episodic growth hormone secretion in the rat
70. Dynamic studies of growth hormone and prolactin secretion in the female rat
71. Females secrete growth hormone with more process irregularity than males in both humans and rats
72. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats
73. Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone
74. Growth and the hypothalamus
75. Characterization of rat hypothalamic growth hormone-releasing factor
76. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: Growth hormone-releasing factor
77. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
78. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland
79. A receptor in pituitary and hypothalamus that functions in growth hormone release
80. The influence of plasma triglycerides on human growth hormone response to arginine and insulin: A study in hyperlipemics and normal subjects
81. The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man
82. Regulation of in vivo growth hormone secretion by leptin
83. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone
84. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat
85. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat
86. Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats
87. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man
88. GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats
89. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
90. A specific growth hormone-binding protein in human plasma: Initial characterization
91. Growth hormone receptor and serum binding protein: Purification, cloning and expression
92. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor
93. Growth hormone binding to a circulating receptor fragment-the concept of receptor shedding and receptor splicing
94. Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence
95. Growth hormone binding protein - Errant receptor or active player?
96. The serum growth hormone binding protein: Pregnant with possibilities
97. Truncated growth hormone receptor isoforms
98. Signaling via JAK tyrosine kinases: Growth hormone receptor as a model system
99. STAT family of transcription factors in cytokine-mediated biological responses
100. Jaks and STATs: Biological implications
101. STAT5b-deficient mice are growth hormone pulse-resistant. Role of STAT5b in sex-specific liver p450 expression
102. Growth hormone, interferon-γ and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling
103. Signalling pathway of GH
104. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1
105. Introduction of exogenous growth hormone receptors augments growth hormone-responsive insulin biosynthesis in rat insulinoma cells
106. Refractoriness to the insulin-like effects of growth hormone depends upon calcium
107. Refractoriness to growth hormone is associated with increased intracellular calcium in rat adipocytes
108. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes
109. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts
110. Role of kinase C in the insulin-like effects of human growth hormone in rat adipocytes
111. Organization and chromosomal localization of the gene encoding the mouse acid labile subunit of the insulin-like growth factor binding complex
112. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex
113. Rapid effects of growth hormone on amino acid transport and protein synthesis
114. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding
115. Effects of human growth hormone in men over 60 years old
116. Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans
117. Effect of growth hormone and resistance exercise on muscle growth in young men
118. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth
119. Growth hormone and insulin combine to improve whole-body and skeletal muscle protein kinetics
120. Human growth hormone prevents the protein catabolic side effects of prednisone in humans
121. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism
122. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats
123. Differential long-term effects of insulin-like growth factor-I (IGF-1) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats
124. Additive effects on body growth of insulin-like growth factor-I and growth hormone in hypophysectomized rats
125. Insulin-like growth factor-I and growth hormone (GH) have distinct and overlapping effects in GH-deficient rats
126. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys
127. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): Effects on the glycemic and growth promoting activities of rhIGF-1 in the rat
128. The growth hormone (GH) gene is expressed in the lateral hypothalamus: Enhancement by GH-releasing hormone and repression by restraint stress
129. Growth hormone and its receptor are expressed in human thymic cells
130. Human neutrophils express GH-N gene transcripts and the pituitary transcription factor Pit-1b
131. Cloning of two novel growth hormone transcripts expressed in human placenta
132. Expression of the gene encoding growth hormone in the human mammary gland
133. The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus
134. Cell kinetics and the control of growth in long bones
135. Growth hormone dependent stimulation of osteoblast-like cells in serum- free cultures via local synthesis of insulin-like growth factor I
136. Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression
137. Growth hormone inhibits lipoprotein lipase activity in human adipose tissue
138. Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes
139. Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities
140. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site
141. Biological activity of bacterial derived human growth hormone in adipose tissue of hypophysectomized rats
142. The glucose-fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
143. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone
144. Growth hormone promotes early initiation of hepatocyte growth factor gene expression in the liver of hypophysectomized rats after partial hepatectomy
145. Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver
146. Growth hormone treatment increases oestrogen receptor concentration in the guinea-pig uterus
147. Growth hormone and insulin-like growth factor I induce bone morphogenetic proteins 2 and 4: A mediator role in bone and tooth formation?
148. Effects of growth hormone and insulin-like growth factor-I on colony formation of rabbit epiphyseal chondrocytes at different stages of maturation
149. The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor-I
150. Insulin-like growth factors and their binding proteins: Biological actions
151. Insulin-like growth factor receptors
152. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
153. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells
154. Role of insulin-like growth factors in embryonic and postnatal growth
155. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
156. Expression and characterization of a functional human insulin-like growth factor I receptor
157. Characterization of insulin-like growth factor I-stimulated tyrosine kinase activity associated with the β-subunit of type I insulin-like growth factor receptors of rat liver cells
158. Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology
159. The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action
160. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor
161. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system
162. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation
163. Role of IRS-1-GRB-2 complexes in insulin signaling
164. Functional roles of the Shc phosphotyrosine binding and Src homology 2 domains in insulin and epidermal growth factor signaling
165. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor
166. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: Possible involvement of PI 3-kinase in IGF-1 signaling
167. IGF binding proteins as modulators of IGF action
168. Insulin-like growth factor binding proteins
169. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain
170. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit
171. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: Manipulation using the Cre/loxP system in transgenic mice
172. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents
173. Genetic selection for insulin-like growth factor-1 in growing mice is associated with altered growth
174. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
175. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome)
176. Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms
177. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin
178. Insulin-like growth factor I receptor β-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers
179. Insulin-like growth factor binding protein-1 induces insulin release in the rat
180. Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man
181. Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance
182. Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance
183. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus
184. The effects of repeated dally recombinant human insulin-like growth factor I administration in adolescents with type 1 diabetes
185. Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus
186. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes
187. Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus
188. Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus
189. In vivo metabolic effects of insulin-like growth factor-I not mediated through the insulin receptor
190. G1 events and regulation of cell proliferation
191. Dual control of cell growth by somatomedins and platelet-derived growth factor
192. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity
193. Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle
194. Diminished G1 checkpoint after γ-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression
195. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes
196. Metallothionein-human GH fusion genes stimulate growth of mice
197. Expression of growth hormone and its receptor in the placental and feto-maternal environment during early pregnancy in sheep
198. Tissue distribution and ontogeny of growth hormone receptor messenger ribonucleic acid and ligand binding to hepatic tissue in the midgestation sheep fetus
199. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth
200. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
201. Expression of insulin-like growth factor 1 stimulates normal somatic growth in growth hormone-deficient transgenic mice
202. Insulin-like growth factor I improves height in growth hormone insensitivity: Two years' results
203. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting
204. Manipulation of transgenes by site-specific recombination: Use of Cre recombinase
205. Transcrirfptional control of the murine albumin/α-fetoprotein locus during development
206. Normal growth and development in the absence of hepatic insulin-like growth factor I
207. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
208. Differential association of insulin-like growth factor I mRNA variants with polysomes in vivo
209. Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by IGF-I and basic fibroblastic growth factor
210. Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels
211. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system
212. Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormone
213. Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia
214. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
215. Administration of growth hormone modulates the gene expression of basic fibroblast growth factor in rat costal cartilage, both in vivo and in vitro
216. Effects of growth hormone on rat renal epidermal growth factor expression
217. Growth hormone and prolactin regulate the expression of nerve growth factor receptors in INS-1 cells
218. Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/ delta-like protein in pancreatic islets: Molecular cloning and expression pattern during development and growth of the endocrine pancreas
219. Growth hormone increases interleukin-6 produced by human osteoblast-like cells
220. Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts
221. The effect of GH on estrogen receptor expression in the rat mammary gland
222. Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation